ReviewMedicina (Kaunas, Lithuania)2024

Antimalarial Drugs at the Intersection of SARS-CoV-2 and Rheumatic Diseases: What Are the Potential Opportunities?

Saule Abisheva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.